IC
DNA icon

IEQ Capital’s Ginkgo Bioworks DNA Stock Holding History

IEQ Capital’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Buy
63,044
+40,418
+179% +$338K ﹤0.01% 1308
2026
Q1 		$139K Buy
+22,626
New +$188K ﹤0.01% 1759
2024
Q3 		– Sell
-411
Closed -$5.5K – 1168
2024
Q2 		$5.5K Sell
411
-2
-0.5% -$60 ﹤0.01% 1001
2024
Q1 		$19.1K Buy
413
+20
+5% +$1.03K ﹤0.01% 966
2023
Q4 		$26.6K Hold
393
– – ﹤0.01% 918
2023
Q3 		$28.5K Hold
393
– – ﹤0.01% 928
2023
Q2 		$29.3K Hold
393
– – ﹤0.01% 890
2023
Q1 		$20.9K Sell
393
-1,046
-73% -$66.3K ﹤0.01% 884
2022
Q4 		$97.3K Buy
+1,439
New +$132K ﹤0.01% 770

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

IEQ Capital's DNA Position: Q2 2026 in Review

IEQ Capital increased its Ginkgo Bioworks (DNA) stake by 179% in Q2 2026, buying an estimated $338K and bringing the position to 63,044 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

IEQ Capital first reported a position in DNA in Q4 2022 and has held it in 9 quarters since. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • IEQ Capital held 63,044 shares of Ginkgo Bioworks worth $625K as of Q2 2026.
  • IEQ Capital bought 40,418 Ginkgo Bioworks shares in Q2 2026, an estimated $338K.
  • Ginkgo Bioworks made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1308 holding.
  • IEQ Capital first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 9 quarters since.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.